Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Northern Ireland: HIV Charity Chief welcomes new HIV Prevention Pilot under Health Transformation Fund

We welcome the latest news from the Department of Health that a new £450,000 HIV prevention pilot programme will be rolled out as part of the recent allocation under the Health Transformation Fund. We understand that as part of that pilot project, Pre-Exposure Prophylaxis (PrEP) will be made available in Northern Ireland for those at high risk of exposure to HIV.

Published
22 hours ago
From
Brown O'Connor Communications
Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis

Long-acting implants for PrEP are currently under development and mimic many aspects of contraceptive implants currently on the market (eg, Nexplanon and Jadelle). The PrEP implants are designed for placement under the skin, where the device resides and releases the ARV drug at a controlled rate over time.

Published
21 June 2018
From
Contagion Live
New Zealand sees drop in people diagnosed with HIV

The number of people diagnosed with HIV in New Zealand has significantly dropped, according to the AIDS Epidemiology Group of Otago University. It has been the first time the number has decreased since 2011. Last year, 197 people were diagnosed, a drop of 46 compared to 2016 when 243 people were diagnosed with HIV. Dr Sue McAllister said despite the drop being encouraging, it was too early to determine whether the decline would be maintained.

Published
20 June 2018
From
1 News Now
#BREAKTHEPATENT

The drug Truvada has the ability to reduce the risk of HIV transmission by more than 99%, but it's being withheld from the American public because of the greed of its manufacturer. Sign the petition to call on the National Institute of Health to break the patent around Truvada as PrEP.

Published
20 June 2018
From
breakthepatent.org
Early adopters of PrEP in Kenya and Uganda more likely to be male and older

It is feasible to offer pre-exposure prophylaxis (PrEP) as part of community-wide HIV testing campaigns in East Africa, with a fifth of adults who were identified

Published
20 June 2018
By
Roger Pebody
Fairfax students to learn about HIV prevention pill in health classes

The Fairfax County School Board voted last week to include information about pre-exposure prophylaxis — PrEP — in the district’s family life education curriculum, which includes lessons on sexual health and sexuality.

Published
19 June 2018
From
Washington Post
Human Immunodeficiency Virus-1 Infection: Developing Systemic Drug Products for Pre-Exposure Prophylaxis

This draft guidance provides general nonclinical and clinical recommendations specific to the development of systemic drug products, with a focus on long-acting systemic drug products for the prevention of sexually acquired human immunodeficiency virus-1 (HIV-1) infection.

Published
18 June 2018
From
US Food and Drug Administration
Zimbabwe launches 'HIV prevention' pill

Government last week launched the pre-exposure prophylaxis strategy (PrEP), which is meant to reduce the risk of contracting HIV. Speaking at the "Million Men Circumcised" celebrations and launch of the PrEP Strategy in Harare on Friday, Minister of Health and Child Care Dr David Parirenyatwa said the oral PrEP was strictly for those who were at a higher risk of contracting HIV.

Published
18 June 2018
From
Bulawayo 24 News
NHS England considers expanding PrEP trial - NAT comment

Deborah Gold, Chief Executive of NAT (National AIDS Trust) said: “This proposed trial expansion, from 10,000 to 13,000 participants, is essential and we urge NHS England to confirm the decision urgently. This expansion was first proposed by NAT as necessary to estimate accurately the likely long-term needs of a routinely commissioned PrEP programme and it’s great news that this is now on the table.

Published
18 June 2018
From
National AIDS Trust
Stigma may keep women from using HIV-prevention drugs

Researchers found that many women feared being stigmatized if they used PrEP. About 37 percent believed they would be thought of as promiscuous, 32 percent thought people would believe they were HIV-positive and trying to disguise their status, and 14 percent thought other people would think they were “bad” people if they took the PrEP.

Published
15 June 2018
From
Reuters
← First12345...139Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.